CO4940470A1 - Compuestos 5,6,7-trisustituidos-4-aminopirido[2,3-d]pirimi- dina - Google Patents

Compuestos 5,6,7-trisustituidos-4-aminopirido[2,3-d]pirimi- dina

Info

Publication number
CO4940470A1
CO4940470A1 CO98020978A CO98020978A CO4940470A1 CO 4940470 A1 CO4940470 A1 CO 4940470A1 CO 98020978 A CO98020978 A CO 98020978A CO 98020978 A CO98020978 A CO 98020978A CO 4940470 A1 CO4940470 A1 CO 4940470A1
Authority
CO
Colombia
Prior art keywords
sub
trisustituidos
aminopirido
pirimi
dina
Prior art date
Application number
CO98020978A
Other languages
English (en)
Spanish (es)
Inventor
S Bhagwat Shripad
Richard J Perner
Gu Yu-Gui
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of CO4940470A1 publication Critical patent/CO4940470A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Transplantation (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Communicable Diseases (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CO98020978A 1997-04-16 1998-04-16 Compuestos 5,6,7-trisustituidos-4-aminopirido[2,3-d]pirimi- dina CO4940470A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84348497A 1997-04-16 1997-04-16

Publications (1)

Publication Number Publication Date
CO4940470A1 true CO4940470A1 (es) 2000-07-24

Family

ID=25290123

Family Applications (1)

Application Number Title Priority Date Filing Date
CO98020978A CO4940470A1 (es) 1997-04-16 1998-04-16 Compuestos 5,6,7-trisustituidos-4-aminopirido[2,3-d]pirimi- dina

Country Status (19)

Country Link
EP (1) EP0975633A1 (xx)
JP (1) JP2001520654A (xx)
KR (1) KR20010006462A (xx)
CN (1) CN1252069A (xx)
AR (1) AR012437A1 (xx)
AU (1) AU741033B2 (xx)
BG (1) BG103853A (xx)
BR (1) BR9809056A (xx)
CA (1) CA2286592A1 (xx)
CO (1) CO4940470A1 (xx)
HU (1) HUP0001443A3 (xx)
IL (1) IL131617A0 (xx)
NO (1) NO995035L (xx)
NZ (1) NZ337125A (xx)
PL (1) PL336265A1 (xx)
SK (1) SK140099A3 (xx)
TR (1) TR199902550T2 (xx)
WO (1) WO1998046604A1 (xx)
ZA (1) ZA983175B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001057040A1 (en) * 2000-02-03 2001-08-09 Abbott Laboratories 6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds
DK1361880T3 (da) 2001-02-12 2006-01-23 Hoffmann La Roche 6-substituerede pyrido-pyrimidiner
CN107744520A (zh) * 2017-10-25 2018-03-02 南京多宝生物科技有限公司 嘧啶类化合物在制备促进小肠蠕动药物中的应用
CN112209924B (zh) * 2019-07-09 2022-04-05 中国科学院天津工业生物技术研究所 选择性腺苷a1受体拮抗剂

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB774094A (en) * 1953-01-02 1957-05-08 Wellcome Found Improvements in or relating to pyrimidine compounds
IL112249A (en) * 1994-01-25 2001-11-25 Warner Lambert Co Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds

Also Published As

Publication number Publication date
AU7108098A (en) 1998-11-11
HUP0001443A3 (en) 2001-01-29
ZA983175B (en) 1998-10-21
BR9809056A (pt) 2000-08-01
PL336265A1 (en) 2000-06-19
CN1252069A (zh) 2000-05-03
NZ337125A (en) 2001-06-29
IL131617A0 (en) 2001-01-28
JP2001520654A (ja) 2001-10-30
BG103853A (en) 2000-06-30
NO995035D0 (no) 1999-10-15
AU741033B2 (en) 2001-11-22
AR012437A1 (es) 2000-10-18
EP0975633A1 (en) 2000-02-02
SK140099A3 (en) 2000-05-16
CA2286592A1 (en) 1998-10-22
NO995035L (no) 1999-12-15
HUP0001443A2 (hu) 2000-10-28
KR20010006462A (ko) 2001-01-26
TR199902550T2 (xx) 2000-04-21
WO1998046604A1 (en) 1998-10-22

Similar Documents

Publication Publication Date Title
WO2003062259A3 (en) Non-aromatic 17.alpha.-esters of androstane-17.beta.-carboxylate esters as anti-inflammatory agents
HUP0301607A2 (hu) Szelektív neurokinin antagonista hatású nitrogéntartalmú heterociklusos vegyületek, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
CY1107001T1 (el) Αζωτουχα ετεροκυκλικα παραγωγα καρβοξαμιδιου ή αλας αυτων ως αντιϊκοι παραγοντες
CY1106679T1 (el) Αζαδικυκλικες ετεροκυκλικες ενωσεις ως τροποποιητες κανναβινοειδους υποδοχεα
NO20023995D0 (no) 2-okso-1-pyrrolidinderivater, fremgangsmåte for fremstilling og anvendelse av disse
EA200970461A1 (ru) ЗАМЕЩЕННЫЕ ПРОИЗВОДНЫЕ 3-ИЗОБУТИЛ-9,10-ДИМЕТОКСИ-1,3,4,6,7,11b-ГЕКСАГИДРО-2Н-ПИРИДО[2,1-a]ИЗОХИНОЛИН-2-ОЛА И СВЯЗАННЫЕ С НИМИ СПОСОБЫ
RS51444B (sr) JEDINJENJA KOJA SADRŽE LAKTAM I NJIHOVI DERIVATI KAO INHIBITORI FAKTORA Xa
EP1775289A4 (en) NEW IMIDAZOLIDINE DERIVATIVES
DE69325454D1 (de) Taxol-derivate
UY29312A1 (es) Piperazin-1-carboxamidas n,4,sustituidas y sus derivados, composiciones que los contienen, procedimientos de preparación y aplicaciones
AR002012A1 (es) Un compuesto, una composicion farmaceutica que lo comprende, su uso, metodo de tratamiento terapeutico, metodo para la preparacion del compuesto.
CY1112899T1 (el) Παραγωγα θειαδιαζολινης για τη θεραπεια του καρκινου
ES2195933T3 (es) Nuevos derivados de flavonas, xantonas y cumarinas.
BRPI0409105A (pt) análogos de quinobenzoxazina substituìdos
MY138826A (en) 2,7-substituted indoles
MXPA04009476A (es) Compuestos de (tiazol-4,2-disustituidos-5-il)amina como inhibidores de la pde7.
AR053989A1 (es) Compuestos espiro-hidantoina sustituidos con piridilo. composiciones farmaceuticas y procesos de obtencion.
AR044175A1 (es) Compuestos de cefemo
CO4940470A1 (es) Compuestos 5,6,7-trisustituidos-4-aminopirido[2,3-d]pirimi- dina
MXPA04009421A (es) Compuestos de tiazol-2-ilimina como inhibidores de la pde-7.
DE69330601T2 (de) Serotoninergische ergolin derivate
CO4940439A1 (es) COMPUESTOS 4-AMINO-6,7-DISUSTITUIDOS-PIRIDO-[2,3-d] PIRIMI- DINA
ES2172294T3 (es) Nuevos derivados del 1-indanol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2189736T3 (es) Derivados de la benzamida y medicamentos que los contienen.
HRP20050617A2 (en) Imidazol derivatives having affinity for alpha 2 receptors activity